By Product (Active Implantable Devices, Biochips, Implantable Materials, Medical Textiles and Wound Dressings, Others. By Application (Therapeutic Applications, Diagnostic Applications, Research Applications) List of Companies Profiled in the Nanotechnology in Medical Devices Market Report are: 3M. Dentsply Sirona. Thermo Fisher Scientific Inc. NanoDrop 8000 Spectrophotometer and once for two devices internal to the instrument. For the NanoDrop 8000 to operate successfully a total of three USB devices need to install although only two cycles through the hardware wizard will be observed. To confirm installation, view the Windows Device Manager as shown below.
- Drivers Thermo Fisher Scientific Port Devices Gigabit
- Drivers Thermo Fisher Scientific Port Devices List
Thermo Fisher Scientific Inc. the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the …
– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction.
Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Mesa Biotech’s patented technology expands the availability of gold standard nucleic acid PCR amplification to point-of-care diagnostics. The company is based in San Diego, California and has approximately 500 employees and revenues in 2020 of approximately $45 million .
Mesa Biotech’s Accula™ Flu A/Flu B, RSV and Strep A tests have obtained 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waivers from the U.S. Food and Drug Administration (FDA). Additionally, the Accula System has received Emergency Use Authorization (EUA) from the FDA for SARS-CoV-2 in vitro diagnostic testing and is now available for use in patient care settings, providing results within 30 minutes, with higher accuracy than other rapid tests on the market.
“Mesa Biotech’s innovative platform will enable us to accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care. Since the start of the pandemic, Thermo Fisher has acted quickly to provide support to the scientists and healthcare professionals at the frontlines of combating COVID-19,” said Mark Stevenson , executive vice president and chief operating officer of Thermo Fisher Scientific. “The addition of Mesa Biotech’s easy-to-use, rapid PCR-based test is highly complementary to our existing offering and will further help us meet the continuing demand for COVID-related testing while we work to rapidly scale and develop point-of care tests for other infectious diseases in the future.”
Ingo Chakravarty , president and chief executive officer of Mesa Biotech said, “I am extremely proud of the remarkable accomplishments Mesa Biotech has achieved to date and excited about the prospects of becoming a part of Thermo Fisher . Mesa’s innovative rapid PCR platform technology, combining PCR accuracy with mobility and test results in 30 minutes, has already played a meaningful role in the collective efforts combating the pandemic. Thermo Fisher’s scale, innovation and global reach will allow us to more significantly amplify the impact our technology will have on human health, during the pandemic, and far beyond.”
The transaction is expected to be completed in the first quarter of 2021, subject to customary closing conditions, including regulatory approval. Upon completion, the business will become part of Thermo Fisher’s Life Sciences Solutions Segment.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion . Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com .
Forward-Looking Statements
This communication contains forward-looking statements that involve a number of risks and uncertainties, including statements about the timing of completion of the transaction. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include risks and uncertainties relating to the proposed transaction not being timely completed, if completed at all; regulatory approval required for the transaction not being timely obtained, if obtained at all, or being obtained subject to conditions; and the additional factors set forth in Thermo Fisher’s most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, which are on file with the Securities and Exchange Commission and available in the “Investors” section of its Website under the heading “SEC Filings.” While Thermo Fisher may elect to update forward-looking statements at some point in the future, Thermo Fisher specifically disclaims any obligation to do so, even if Thermo Fisher’s estimates change and, therefore, you should not rely on these forward-looking statements as representing Thermo Fisher’s views as of any date subsequent to the date of this communication.
Media Contact Information:
Thermo Fisher
Ron O’Brien
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com
Investor Contact Information:
Thermo Fisher
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com
View original content to download multimedia: http://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-acquire-point-of-care-molecular-diagnostics-provider-mesa-biotech-301210467.html
SOURCE Thermo Fisher Scientific
News Provided by PR Newswire via QuoteMedia
Life Science and Healthcare Investing in 2021
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
According to a new report published by Zeal Insider, titled, “Global Automated Analyzers Market (2018-2025) – Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application“ The report has offered an all-inclusive analysis of the global Automated Analyzers market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the start, the report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth.
The global Automated Analyzers market research report covers detailed analysis of regional level break-up, market size, status, leading growth rate, highest market shares for countries, geographical break-up, and upcoming technologies. The report focuses on classifying various market trends, dynamics, industry growth drivers, challenges, regulatory policies and factors restraining the market growth. The report also offers comprehensive evaluation of the market, complete understandings about various growth opportunities and segmentation of the Automated Analyzers market based on types, applications, end users and geography.
Get Free Exclusive Sample PDF along with few company profiles:
- Thermo Fisher Scientific
- Danaher
- Becton Dickinson
- Agilent Technologies
- Siemens
- Shimadzu
- Honeywell International
- Hudson Robotics
- Synchron Lab Automation
- Perkinelmer
- Bio-Rad
- Aurora Biomed
- Eppendorf AG
Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @: https://www.zealinsider.com/report/103960/automated-analyzers-market#sample
| Report Attribute | Details |
|---|---|
| The market size value in 2019 | USD xx.xx million (click here for value) |
| The revenue forecast in 2028 | USD xx.xx million (click here for value) |
| Growth Rate | CAGR of xx.xx% from 2020 to 2028 (click here for value) |
| The base year for estimation | 2019 |
| Historical data | 2015 – 2018 |
| Forecast period | 2019 – 2028 |
| Quantitative units | Revenue in USD million and CAGR from 2020 to 2028 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Component, Types, Applications, End-Users, and more. |
| Top Manufacturers | Thermo Fisher Scientific, Danaher, Becton Dickinson, Agilent Technologies, Siemens, Shimadzu, Honeywell International, Hudson Robotics, Synchron Lab Automation, Perkinelmer, Bio-Rad, Aurora Biomed, Eppendorf AG |
| Product Types | Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Others |
| Application Types | Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Others |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Customization scope | Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail of customized purchase options to meet your exact research needs. Explore purchase options |
Report Scope:
- Overview of the global Automated Analyzers market
- Information related to the ongoing research and development projects and pipeline research and development projects
- Regional market trends analysis with numerical data corresponding to market size for the years 2018 and 2019
- Global Automated Analyzers market estimates for 2020 and growth forecast for the period from 2020 to 2028
- Company profiling of key manufacturers of the Automated Analyzers market, along with their complete insights about product offerings, revenue information, marketing strategies, and recent market activities
- Impact of COVID-19 pandemic on the growth of the Automated Analyzers market
- Based on company’s performance and customer reach, competitive landscape analysis of the global Automated Analyzers market
- Based on various segments of the market, such as product type, application, end user etc., the report covers attractive investment proposals by the marketers
- Technological strategies that are used by the key players and forecast growth areas of the global Automated Analyzers Market
- The drivers and restraints leading the market growth along with future trend analysis
Report Overview:
The study of the market research report focuses on global perspective in terms of the various segments in the Automated Analyzers market. The market is categorized based on type, application and end-use industry. In addition, report provides market sizing and forecast for 5 geographic regions, such as North America, Europe, Asia-Pacific, Middle East and Africa (MEA) and Latin America. The data that is provided in the Automated Analyzers market research report for market sizing is in US dollar. The report provides historic data for the years 2018 and 2019, and the projection and estimations that are provides in the report are from 2020 to 2028.
The Coronavirus (COVID-19) pandemic has affected the overall international import and export for the business. The research report provides changes in the market conditions and latest insights into the Automated Analyzers market. The report also covers rapidly altering market scenario and market fluctuation during the forecast period.
Market Segmentation:
Based on the type, the market is segmented into
- Biochemistry Analyzers
- Immuno-Based Analyzers
- Hematology Analyzers
- Others
Based on the application, the market is segregated into
- Drug Discovery
- Genomics
- Proteomics
- Bio Analysis
- Clinical Diagnostics
- Others
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.zealinsider.com/report/103960/automated-analyzers-market#inquiry
Automated Analyzers Market, by Geography:
- Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
- Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
- North America (the United States, Mexico, and Canada.)
- South America (Brazil etc.)
- The Middle East and Africa (GCC Countries and Egypt.)
Buy single user with discounted price now: https://www.zealinsider.com/checkout?reportId=103960&&usert=su
About Us:
Drivers Thermo Fisher Scientific Port Devices Gigabit
We at Zeal Insider aim to be global leaders in qualitative and predictive analysis as we put ourselves in the front seat for identifying worldwide industrial trends and opportunities and mapping them out for you on a silver platter. We specialize in identifying the calibers of the market’s robust activities and constantly pushing out the areas which allow our clientele base in making the most innovative, optimized, integrated and strategic business decisions in order to put them ahead of their competition by leaps and bounds. Our researchers achieve this mammoth of a task by conducting sound research through many data points scattered through carefully placed equatorial regions.
Drivers Thermo Fisher Scientific Port Devices List
Contact Us:
Zeal Insider
1st Floor, Harikrishna Building,
Samarth Nagar, New Sanghvi,
Pune- 411027 India
tel: +91-8149441100 (GMT Office Hours)
tel: +17738002974
sales@zealinsider.com